BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know

All NewsAugust 27, 2025

BioXcel Therapeutics shares surged over 19% after hours ahead of key Phase 3 trial results for its at-home agitation treatment, sparking strong investor interest.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent